Why the study?
Idiopathic ventricular fibrillation treatment is not mechanistic-based due to a lack of experimental patient models.
Absolute Event Rate: 32.3% vs 15.3%
Integrating iPSC-derived cardiomyocytes with computational modeling provides a novel proof-of-concept methodology to investigate cellular arrhythmia mechanisms and potential therapies in idiopathic ventricular fibrillation.
Idiopathic ventricular fibrillation (IVF) is an unrefined diagnosis representing a heterogeneous patient group without a structural or genetic definition. IVF treatment is not mechanistic-based due to the lack of experimental patient-models. We sought to create a methodology to assess cellular arrhythmia mechanisms for IVF as a proof-of-concept study. Using IVF patient-specific induced pluripotent stem cell-derived cardiomyocytes, we integrate electrophysiological optical mapping with computational modeling to characterize the cellular phenotype. This approach flips the traditional paradigm using a biophysically detailed computational model to solve the problem inversely. Insight into the cellular mechanisms of this patient's IVF phenotype could also serve as a therapeutic testbed.
No takes yet. Share an insight, caveat, or question.
Reilly et al. (2024) studied Idiopathic ventricular fibrillation (n=1). Patient-specific IVF iPSC-CMs vs. Healthy control iPSC-CMs was evaluated on Proarrhythmic behavior at 0.5 Hz pacing.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: